Business Standard

Wednesday, January 08, 2025 | 03:19 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Chinese Covid vaccine's efficacy uncertain despite Brazil, Turkey results

Sinovac is finalising results of phase III trials carried out in Brazil, Turkey, Indonesia and Chile, according to a person familiar with the trials

Coronavirus, vaccine, covid, drugs, clinical trials
Premium

The delay in the announcement of definitive results has created confusion over the effectiveness of Sinovac’s shot.

Bloomberg
With trials of Sinovac Biotech’s coronavirus vaccine in Brazil and Turkey suggesting the shot has a protection rate on either side of 90 per cent, there is still no final assessment on exactly how effective it is in protecting people against Covid-19.
 
Sinovac is finalising results of phase III trials carried out in Brazil, Turkey, Indonesia and Chile, according to a person familiar with the trials. Those tests are relatively independent from each other and conducted according to different protocols, rather than subject to unified norms that typically govern such trials, said the person, who asked not to be

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in